The effects of adrenergic stimulation on platelet aggregation (platelet aggregation ratio; PAR), β-thromboglobulin (β -TG) release and plasma thromboxane B2 (T×B2) levels were investigated in 25 healthy young volunteers. Adrenergic stimulation induced by cold application was checked by evaluating the changes in the calculated vascular resistance in the forearm. A prompt increase in platelet aggregates and plasma β -TG and T×B2 concentrations was observed after adrenergic stimulation. PAR changed from resting values of 0.97 ± 0.05 to 0.75 ± 0.08 (p < 0.001) at the end of cold application. At the same time, β -TG plasma concentration increased from 32.09 ± 19.64 to 135.48 ± 37.97 ng/ml (p < 0.001) and T×B2 plasma levels changed from 0.49 ± 0.24 to 0.99 ± 0.39 pmol/ml (p < 0.001). TxB2 levels, but not PAR and β -TG concentration came back to the resting values at the end of the observation period (10 min). Aspirin, as the lysine acetylsalicylate equivalent to 5 mg/kg i.v. of acetylsalicylic acid, although able to completely inhibit platelet cyclooxygenase failed to inhibit the plasma T×B2 increase induced by adrenergic stimulation. This strongly suggests that the increase in plasma T×B2 following adrenergic stimulation is of extraplatelet origin. Also β-TG and PAR changes were not affected by aspirin administration.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.